C-X-C motif chemokine ligand 13
CXCL13proteinCXCL13 recruits B cells and reprograms macrophages into pro-thrombotic niches, intensifying plaque inflammation.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleB-cell recruitment and macrophage reprogramming; drives pro-thrombotic inflammation.
Also acts inPlatelet activation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000156234
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I36
C — confounder / Type-II60
A — assay feasibility68
E — evidence strength23
T1DI (composite)6
Specificity differential (R−C)-24.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.European heart journal · 2026 · PMID 40905492 · doi
- Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2.Cell · 2025 · PMID 39938515 · doi